118 filings
Page 2 of 6
8-K
xz5ozf
2 Nov 23
Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
7:41am
8-K
5teja6gcudfkl1
12 Sep 23
Other Events
7:00am
8-K
7es23ywh2gqbc
24 Aug 23
Regulation FD Disclosure
7:00am
8-K
sxx2y9k
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
424B5
j748zsl l339xc
28 Jun 23
Prospectus supplement for primary offering
7:32am
8-K
o38r52n8lbdh3i j6d
28 Jun 23
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
7:27am
8-K
0owv166d42l4l
12 Jun 23
Submission of Matters to a Vote of Security Holders
7:41am
8-K
hynk95ih
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
979e6itn14 k2q00vpi
1 May 23
Departure of Directors or Certain Officers
7:30am
ARS
y9w o7zl7ks1z89
24 Apr 23
Annual report to shareholders
4:45pm
DEFA14A
3yg1zhfm0j5e
24 Apr 23
Additional proxy soliciting materials
4:44pm
8-K
9udigovi2wo3y5dtzn
19 Apr 23
Developing disease-modifying medicines for degenerative disorders Analyst Breakfast April 2023
7:30am
8-K
qfmkat1yck w8
28 Mar 23
Other Events
7:36am
424B5
zq4towi1vde0ihmxxbz9
27 Mar 23
Prospectus supplement for primary offering
4:05pm
S-8
k9sph
23 Mar 23
Registration of securities for employees
4:06pm
8-K
zecz795q z2imva
23 Mar 23
Cognition Therapeutics Reports Year End 2022 Financial Results and Provides Business Update
7:35am